• bitcoinBitcoin(BTC)$81,017.004.50%
  • ethereumEthereum(ETH)$2,626.415.69%
  • tetherTether(USDT)$1.000.04%
  • binancecoinBNB(BNB)$761.761.00%
  • rippleXRP(XRP)$1.427.64%
  • usd-coinUSDC(USDC)$1.000.02%
  • solanaSolana(SOL)$111.806.03%
  • tronTRON(TRX)$0.3377560.57%
  • zcashZcash(ZEC)$1,562.304.68%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.030.23%
  • HyperliquidHyperliquid(HYPE)$93.075.98%
  • dogecoinDogecoin(DOGE)$0.0871043.52%
  • moneroMonero(XMR)$572.848.17%
  • whitebitWhiteBIT Coin(WBT)$83.154.11%
  • RainRain(RAIN)$0.0137505.23%
  • USDSUSDS(USDS)$1.000.01%
  • chainlinkChainlink(LINK)$12.344.62%
  • cardanoCardano(ADA)$0.2231774.69%
  • leo-tokenLEO Token(LEO)$8.89-0.23%
  • stellarStellar(XLM)$0.1934463.82%
  • uniswapUniswap(UNI)$9.166.35%
  • bitcoin-cashBitcoin Cash(BCH)$247.440.32%
  • nearNEAR Protocol(NEAR)$3.737.37%
  • Ethena USDeEthena USDe(USDE)$1.000.04%
  • daiDai(DAI)$1.000.01%
  • litecoinLitecoin(LTC)$57.244.18%
  • CantonCanton(CC)$0.1102121.01%
  • USD1USD1(USD1)$1.000.06%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.360.60%
  • avalanche-2Avalanche(AVAX)$8.487.30%
  • hedera-hashgraphHedera(HBAR)$0.0789703.95%
  • suiSui(SUI)$0.825.07%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • shiba-inuShiba Inu(SHIB)$0.0000051.55%
  • crypto-com-chainCronos(CRO)$0.0591620.86%
  • MemeCoreMemeCore(M)$1.28-0.17%
  • BittensorBittensor(TAO)$255.324.89%
  • paypal-usdPayPal USD(PYUSD)$1.000.01%
  • tether-goldTether Gold(XAUT)$4,371.78-0.37%
  • Circle USYCCircle USYC(USYC)$1.140.03%
  • okbOKB(OKB)$116.402.05%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.23%
  • aaveAave(AAVE)$143.136.17%
  • AsterAster(ASTER)$0.760.90%
  • mantleMantle(MNT)$0.613.89%
  • OndoOndo(ONDO)$0.3982743.36%
  • Pump.funPump.fun(PUMP)$0.004109-3.62%
  • MorphoMorpho(MORPHO)$2.7418.33%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

USCB Financial Holdings, Inc. (USCB) Q2 2025 Earnings Call Transcript

July 25, 2025
in Market & News
Reading Time: 2 mins read
A A
USCB Financial Holdings, Inc. (USCB) Q2 2025 Earnings Call Transcript
ShareShareShareShareShare

USCB Financial Holdings, Inc. (NASDAQ:USCB) Q2 2025 Earnings Conference Call July 25, 2025 11:00 AM ET

Company Participants

YOU MAY ALSO LIKE

Woman gives birth in underground bunker as war with Russia continues above ground

GOP Rep. says midterms ‘won’t go well for us’ if party focuses on ‘fighting about Lake Ontario’

Luis F. de la Aguilera – President, CEO & Chairman
Robert B. Anderson – Executive VP & CFO
William Turner – Executive VP & Chief Credit Officer

Conference Call Participants

Feddie Justin Strickland – Hovde Group, LLC, Research Division
Michael Edward Rose – Raymond James & Associates, Inc., Research Division
William Bradford Jones – Keefe, Bruyette, & Woods, Inc., Research Division

Operator

Good morning, everyone, and welcome to the Q2 2025 USCB Financial Holdings, Inc. Earnings Conference Call. [Operator Instructions] Please also note, today’s event is being recorded.

At this time, I’d like to turn the floor over to Mr. Luis de la Aguilera, CEO. Sir, please go ahead.

Luis F. de la Aguilera

Thank you, and good morning. Thank you for joining us for USCB Financial Holdings 2025 Second Quarter Earnings Call. With me today reviewing our Q2 highlights is CFO, Rob Anderson; and Chief Credit Officer, Bill Turner, who will provide an overview of the bank’s performance, the highlights of which commence on Slide 3.

I’m very pleased to report that U.S. Century Bank delivered another consecutive record quarter with continued improvement in our profitability ratios, posting a return on average equity of 14.29%, a return on average assets of 1.22% and a fully diluted earnings per share of $0.40 compared to $0.31 per fully diluted share for the same period in 2024. This past Monday, the bank marked its fourth anniversary since launching a successful IPO on July 21, 2021. Since then, management’s overarching focus has been to safely grow the bank as a high-performing franchise while prudently managing risk and capital allocation to deliver long-term value to our shareholders. That goal remains our efforts continue and as always, the team executes on a clearly defined and communicated business plan.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Woman gives birth in underground bunker as war with Russia continues above ground
Market & News

Woman gives birth in underground bunker as war with Russia continues above ground

September 19, 2026
GOP Rep. says midterms ‘won’t go well for us’ if party focuses on ‘fighting about Lake Ontario’
Market & News

GOP Rep. says midterms ‘won’t go well for us’ if party focuses on ‘fighting about Lake Ontario’

September 19, 2026
U.S. energy companies agree on deals for Venezuelan oil
Market & News

U.S. energy companies agree on deals for Venezuelan oil

September 19, 2026
Judge to deadlocked Lindsay Clancy jurors: A verdict is ‘desirable’
Market & News

Judge to deadlocked Lindsay Clancy jurors: A verdict is ‘desirable’

September 19, 2026
Next Post
15 kids born via surrogates taken into protective custody from a CA home

15 kids born via surrogates taken into protective custody from a CA home

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
How to read the news, buy luxury watches and invest in sports teams

How to read the news, buy luxury watches and invest in sports teams

September 14, 2026
Ukrainian troops innovate as drone warfare intensifies

Ukrainian troops innovate as drone warfare intensifies

September 17, 2026
TransCode Therapeutics, Inc. (RNAZ) Discusses Advancing Multi-Platform Oncology Pipeline Targeting Metastatic Cancer Transcript

TransCode Therapeutics, Inc. (RNAZ) Discusses Advancing Multi-Platform Oncology Pipeline Targeting Metastatic Cancer Transcript

September 17, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!